MetLife Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $31.4M | Sell |
1,303,824
-24,632
| -2% | -$644K | 0.14% | 93 |
|
|
2026
Q1 | $37.3M | Sell |
1,328,456
-34,474
| -3% | -$918K | 0.19% | 75 |
|
|
2025
Q4 | $33.9M | Sell |
1,362,930
-47,688
| -3% | -$1.2M | 0.16% | 87 |
|
|
2025
Q3 | $35.9M | Sell |
1,410,618
-37,970
| -3% | -$937K | 0.17% | 87 |
|
|
2025
Q2 | $35.1M | Sell |
1,448,588
-23,392
| -2% | -$546K | 0.21% | 74 |
|
|
2025
Q1 | $37.3M | Sell |
1,471,980
-28,046
| -2% | -$734K | 0.2% | 72 |
|
|
2024
Q4 | $39.8M | Buy |
1,500,026
+26,451
| +2% | +$717K | 0.22% | 69 |
|
|
2024
Q3 | $42.6M | Sell |
1,473,575
-37,969
| -3% | -$1.11M | 0.24% | 61 |
|
|
2024
Q2 | $42.3M | Buy |
1,511,544
+189,344
| +14% | +$5.21M | 0.25% | 58 |
|
|
2024
Q1 | $36.7M | Sell |
1,322,200
-48,619
| -4% | -$1.35M | 0.25% | 62 |
|
|
2023
Q4 | $39.5M | Sell |
1,370,819
-25,811
| -2% | -$780K | 0.28% | 52 |
|
|
2023
Q3 | $46.3M | Sell |
1,396,630
-36,386
| -3% | -$1.29M | 0.36% | 37 |
|
|
2023
Q2 | $52.6M | Sell |
1,433,016
-16,481
| -1% | -$641K | 0.38% | 36 |
|
|
2023
Q1 | $59.1M | Sell |
1,449,497
-17,355
| -1% | -$750K | 0.43% | 30 |
|
|
2022
Q4 | $75.2M | Sell |
1,466,852
-23,754
| -2% | -$1.14M | 0.57% | 24 |
|
|
2022
Q3 | $65.2M | Sell |
1,490,606
-21,875
| -1% | -$1.06M | 0.54% | 25 |
|
|
2022
Q2 | $79.3M | Sell |
1,512,481
-14,196
| -0.9% | -$723K | 0.61% | 22 |
|
|
2022
Q1 | $79M | Buy |
1,526,677
+286,558
| +23% | +$14.9M | 0.51% | 25 |
|
|
2021
Q4 | $73.2M | Sell |
1,240,119
-26,214
| -2% | -$1.3M | 0.6% | 19 |
|
|
2021
Q3 | $54.5M | Sell |
1,266,333
-31,469
| -2% | -$1.39M | 0.49% | 28 |
|
|
2021
Q2 | $50.8M | Sell |
1,297,802
-31,345
| -2% | -$1.22M | 0.45% | 31 |
|
|
2021
Q1 | $48.2M | Sell |
1,329,147
-20,742
| -2% | -$736K | 0.44% | 31 |
|
|
2020
Q4 | $49.7M | Sell |
1,349,889
-135,106
| -9% | -$4.96M | 0.47% | 30 |
|
|
2020
Q3 | $51.7M | Sell |
1,484,995
-46,253
| -3% | -$1.62M | 0.57% | 26 |
|
|
2020
Q2 | $47.5M | Buy |
1,531,248
+27,726
| +2% | +$942K | 0.54% | 28 |
|
|
2020
Q1 | $46.6M | Sell |
1,503,522
-46,001
| -3% | -$1.57M | 0.63% | 20 |
|
|
2019
Q4 | $57.6M | Sell |
1,549,523
-36,959
| -2% | -$1.32M | 0.6% | 25 |
|
|
2019
Q3 | $54.1M | Sell |
1,586,482
-26,448
| -2% | -$962K | 0.59% | 30 |
|
|
2019
Q2 | $66.3M | Sell |
1,612,930
-50,726
| -3% | -$2.01M | 0.71% | 18 |
|
|
2019
Q1 | $67M | Sell |
1,663,656
-78,756
| -5% | -$3.15M | 0.73% | 20 |
|
|
2018
Q4 | $72.2M | Sell |
1,742,412
-54,911
| -3% | -$2.28M | 0.88% | 13 |
|
|
2018
Q3 | $75.1M | Sell |
1,797,323
-17,644
| -1% | -$679K | 0.77% | 15 |
|
|
2018
Q2 | $62.5M | Sell |
1,814,967
-73,221
| -4% | -$2.5M | 0.74% | 19 |
|
|
2018
Q1 | $63.6M | Sell |
1,888,188
-55,696
| -3% | -$1.91M | 0.75% | 16 |
|
|
2017
Q4 | $66.8M | Buy |
+1,943,884
| New | +$66.3M | 0.76% | 18 |
|
Other funds holding PFE
MetLife Investment Management's PFE Position: Q2 2026 in Review
MetLife Investment Management reduced its Pfizer (PFE) stake by 1.9% in Q2 2026, selling an estimated $644K and leaving 1,303,824 shares worth $31.4M. The position accounts for 0.14% of the portfolio, ranked #93.
MetLife Investment Management first reported a position in PFE in Q4 2017 and has held it in 35 quarters since. The position peaked at $79.3M in Q2 2022. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- MetLife Investment Management held 1,303,824 shares of Pfizer worth $31.4M as of Q2 2026.
- MetLife Investment Management sold 24,632 Pfizer shares in Q2 2026, an estimated $644K.
- Pfizer made up 0.14% of MetLife Investment Management's portfolio in Q2 2026, its #93 holding.
- MetLife Investment Management first reported a position in Pfizer in Q4 2017 and has held it in 35 quarters since.
- MetLife Investment Management's Pfizer position peaked at $79.3M in Q2 2022.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.